Eriksson, Yohanna
Boström, Martina
Sandelius, Åsa
Blennow, Kaj
Zetterberg, Henrik
Kuhn, Georg
Kalm, Marie http://orcid.org/0000-0002-0680-5040
Article History
Received: 16 March 2018
Revised: 8 June 2018
Accepted: 11 June 2018
First Online: 10 July 2018
Conflict of interest
: Authors K.B. and H.Z. are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. H.Z. has served at advisory boards of Eli Lilly and Roche Diagnostics and has received travel support from Teva. The remaining authors declare that they have no conflict of interest.